SCHEMBL230254

SCHEMBL230254

COC(=O)c1cc(N)cc(C(=O)c2ccc(Nc3ccc(Cl)cc3)cc2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.49
HPGD P15428 5/20 0.49
ALDH1A1 P00352 5/20 0.49
KDM4E B2RXH2 3/20 0.49
LMNA P02545 2/20 0.49
NPSR1 Q6W5P4 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
KDR P35968 1/20 0.48
POLB P06746 1/20 0.46
MAPK1 P28482 1/20 0.46
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
USP2 O75604 1/20 0.44
DHODH Q02127 1/20 0.44
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
GLA P06280 1/20 0.43
GAA P10253 1/20 0.43
CASP1 P29466 1/20 0.43
CASP7 P55210 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL230366 0.90 MAPT (0.51) MAPTHPGDALDH1A1KDM4ELMNA
SCHEMBL230032 0.84 MAPT (0.44) MAPTHPGDALDH1A1KDM4ELMNA
SCHEMBL229926 0.82 MEN1 (0.57) MAPTHPGDALDH1A1POLBMAPK1
SCHEMBL28266243 0.81 DHODH (0.58) MAPTHPGDALDH1A1KDM4ELMNA
SCHEMBL2722651 0.81 NPC1 (0.53) MAPTHPGDALDH1A1KDM4ELMNA
SCHEMBL231538 0.78 ABL1 (0.49) MAPTHPGDALDH1A1KDM4ELMNA
SCHEMBL27334844 0.77 MAPT (0.52) MAPTHPGDALDH1A1KDM4ELMNA
SCHEMBL3297101 0.77 HPGD (0.66) MAPTHPGDALDH1A1LMNAMAPK1
SCHEMBL27676963 0.77 SRD5A2 (0.57) MAPTHPGDALDH1A1KDM4ELMNA
SCHEMBL232108 0.77 MAPT (0.44) MAPTHPGDALDH1A1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2406220-A1 BIS AROMATIC COMPOUNDS FOR USE AS LTC4 SYNTHASE INHIBITORS Biolipox AB (SE) 2012-01-18 EP disclosed
US-20120004228-A1 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors BIOLIPOX AB (SW) 2012-01-05 US disclosed
WO-2010103279-A1 BIS AROMATIC COMPOUNDS FOR USE AS LCT4 SYNTHASE INHIBITORS BIOLIPOX AB (SE) 2010-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120004228-A1 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors LTC4S, LTB4R2, LTB4R MAPT 4117/4885HPGD 169/4885ALDH1A1 453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.